EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Progress in the study of pentraxin-3(PTX-3) as a biomarker for sepsis

Yi Zhang, Xuelin Li, Xiaobei Zhang, Tiantian Wang, Xiangcheng Zhang

Frontiers in Medicine · 03.07.2024 · 11

DOI: 10.3389/fmed.2024.1398024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Medicine, online erschienen am 03.07.2024. Verfasst von Yi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The Affiliated Huai'an No 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a intricate pathological process characterized by life-threatening organ dysfunction resulting from a dysregulated host response to infection. It stands as a prominent cause of mortality among critically ill patients globally. The pivotal focus in sepsis management lies in the early identification and prompt administration of antimicrobial agents. Owing to the constraints of current diagnostic methodologies, marked by insufficient sensitivity and delayed outcomes, extensive research has been undertaken to ascertain novel biomarkers for sepsis. In this review, we provide an overview discussing the latest advancements in the study of PTX-3 as a biomarker for sepsis. We acknowledge pivotal discoveries from preceding research and engage in discourse regarding the challenges and limitations confronted by PTX-3 as a sepsis biomarker.

Schlagwörter

Stichwörter der Autor:innen

biomarkerdiagnosispentraxin-3 (PTX-3)prognosissepsis

Autor:innen und Institutionen

  • Department of Critical Care Medicine, The Affiliated Huai'an No 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.

Zitieren

APA

Zhang, Y., Li, X., Zhang, X., Wang, T., & Zhang, X. (2024). Progress in the study of pentraxin-3(PTX-3) as a biomarker for sepsis. Frontiers in Medicine, 11. https://doi.org/10.3389/fmed.2024.1398024

Vancouver

Zhang Y, Li X, Zhang X, Wang T, Zhang X. Progress in the study of pentraxin-3(PTX-3) as a biomarker for sepsis. Frontiers in Medicine. 2024;11. doi:10.3389/fmed.2024.1398024

BibTeX
@article{Zhang2024,
  author = {Zhang, Yi and Li, Xuelin and Zhang, Xiaobei and Wang, Tiantian and Zhang, Xiangcheng},
  title = {Progress in the study of pentraxin-3(PTX-3) as a biomarker for sepsis},
  journal = {Frontiers in Medicine},
  year = {2024},
  volume = {11},
  doi = {10.3389/fmed.2024.1398024}
}
Kostenlos starten →